To gain insight into how the expression of CYP2E1 was altered in lung cancer, we quantified the level of CYP2E1 in the peritumoral tissues of non‐small cell lung cancer (NSCLC) patients. The gene discussed is CYP2E1; the disease is lung carcinoma.